<VariationArchive VariationID="520752" VariationName="NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs)" VariationType="Deletion" Accession="VCV000520752" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-05" DateCreated="2018-04-15" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="511952" VariationID="520752">
      <GeneList>
        <Gene Symbol="GNPTAB" FullName="N-acetylglucosamine-1-phosphate transferase subunits alpha and beta" GeneID="79158" HGNC_ID="HGNC:29670" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="101745499" stop="101830959" display_start="101745499" display_stop="101830959" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="102139274" stop="102224644" display_start="102139274" display_stop="102224644" Strand="-" />
          </Location>
          <OMIM>607840</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs)</Name>
      <CanonicalSPDI>NC_000012.12:101764956:TA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="101764957" stop="101764958" display_start="101764957" display_stop="101764958" variantLength="2" positionVCF="101764956" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="102158735" stop="102158736" display_start="102158735" display_stop="102158736" variantLength="2" positionVCF="102158734" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P655fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.102158735_102158736del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.102158735_102158736del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.101764957_101764958del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.101764957_101764958del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021243.1" sequenceAccession="NG_021243" sequenceVersion="1" change="g.70910_70911del">
            <Expression>NG_021243.1:g.70910_70911del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024312.5" sequenceAccession="NM_024312" sequenceVersion="5" change="c.1959_1960del" MANESelect="true">
            <Expression>NM_024312.5:c.1959_1960del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077288.2" sequenceAccession="NP_077288" sequenceVersion="2" change="p.Pro655fs">
            <Expression>NP_077288.2:p.Pro655fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA607597818" DB="ClinGen" />
        <XRef Type="rs" ID="1429181351" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs) AND Inborn genetic diseases" Accession="RCV000623566" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs) AND Pseudo-Hurler polydystrophy" Accession="RCV000853306" Version="1">
        <ClassifiedConditionList TraitSetID="710">
          <ClassifiedCondition DB="MedGen" ID="C0033788">Pseudo-Hurler polydystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-25" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs) AND Mucolipidosis type II" Accession="RCV001329953" Version="1">
        <ClassifiedConditionList TraitSetID="711">
          <ClassifiedCondition DB="MedGen" ID="C2673377">Mucolipidosis type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024312.5(GNPTAB):c.1959_1960del (p.Pro655fs) AND multiple conditions" Accession="RCV003767822" Version="1">
        <ClassifiedConditionList TraitSetID="9397">
          <ClassifiedCondition DB="MedGen" ID="C2673377">Mucolipidosis type II</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0033788">Pseudo-Hurler polydystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-05" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-15" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19617216</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25107912</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34645491</ID>
        </Citation>
        <DescriptionHistory Dated="2019-10-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9397" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3038" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ML II ALPHA/BETA</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucolipidosis type II</ElementValue>
                <XRef ID="MONDO:0009650" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">I cell disease</ElementValue>
                <XRef ID="Mucolipidosis+II/3706" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion cell disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leroy Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylglucosamine 1phosphotransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML disorder type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICD</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ML II</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GNPTA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GNPTAB-related disorders comprise the phenotypes mucolipidosis II (ML II) and mucolipidosis IIIa/ß (ML IIIa/ß), and phenotypes intermediate between ML II and ML IIIa/ß. ML II is evident at birth and slowly progressive; death most often occurs in early childhood. Orthopedic abnormalities present at birth may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s). Growth often ceases in the second year of life; contractures develop in all large joints. The skin is thickened, facial features are coarse, and gingiva are hypertrophic. All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve. Progressive mucosal thickening narrows the airways, and gradual stiffening of the thoracic cage contributes to respiratory insufficiency, the most common cause of death. ML IIIa/ß becomes evident at about age three years with slow growth rate and short stature; joint stiffness and pain initially in the shoulders, hips, and fingers; gradual mild coarsening of facial features; and normal to mildly impaired cognitive development. Pain from osteoporosis becomes more severe during adolescence. Cardiorespiratory complications (restrictive lung disease, thickening and insufficiency of the mitral and aortic valves, left and/or right ventricular hypertrophy) are common causes of death, typically in early to middle adulthood. Phenotypes intermediate between ML II and ML IIIa/ß are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML IIIa/ß.</Attribute>
                <XRef ID="NBK1828" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GNPTAB-Related Mucolipidoses</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6749" />
                <XRef ID="6749" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301728</ID>
                <ID Source="BookShelf">NBK1828</ID>
              </Citation>
              <XRef ID="576" DB="Orphanet" />
              <XRef ID="C2673377" DB="MedGen" />
              <XRef ID="MONDO:0009650" DB="MONDO" />
              <XRef Type="MIM" ID="252500" DB="OMIM" />
            </Trait>
            <Trait ID="3039" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis type 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML III</ElementValue>
                <XRef Type="MIM" ID="252600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML III ALPHA/BETA</ElementValue>
                <XRef Type="MIM" ID="252600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML IIIA</ElementValue>
                <XRef Type="MIM" ID="252600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML 3 A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudo-Hurler polydystrophy</ElementValue>
                <XRef ID="Mucolipidosis+type+3A/4909" DB="Genetic Alliance" />
                <XRef ID="65764006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis III Alpha/Beta</ElementValue>
                <XRef ID="NBK1875" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type III Mucolipidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ML3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3806" />
                <XRef ID="3806" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GNPTAB-Related Mucolipidoses</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNPTAB-related disorders comprise the phenotypes mucolipidosis II (ML II) and mucolipidosis IIIa/ß (ML IIIa/ß), and phenotypes intermediate between ML II and ML IIIa/ß. ML II is evident at birth and slowly progressive; death most often occurs in early childhood. Orthopedic abnormalities present at birth may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s). Growth often ceases in the second year of life; contractures develop in all large joints. The skin is thickened, facial features are coarse, and gingiva are hypertrophic. All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve. Progressive mucosal thickening narrows the airways, and gradual stiffening of the thoracic cage contributes to respiratory insufficiency, the most common cause of death. ML IIIa/ß becomes evident at about age three years with slow growth rate and short stature; joint stiffness and pain initially in the shoulders, hips, and fingers; gradual mild coarsening of facial features; and normal to mildly impaired cognitive development. Pain from osteoporosis becomes more severe during adolescence. Cardiorespiratory complications (restrictive lung disease, thickening and insufficiency of the mitral and aortic valves, left and/or right ventricular hypertrophy) are common causes of death, typically in early to middle adulthood. Phenotypes intermediate between ML II and ML IIIa/ß are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML IIIa/ß.</Attribute>
                <XRef ID="NBK1828" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301728</ID>
                <ID Source="BookShelf">NBK1828</ID>
              </Citation>
              <XRef ID="423461" DB="Orphanet" />
              <XRef ID="577" DB="Orphanet" />
              <XRef ID="C0033788" DB="MedGen" />
              <XRef ID="MONDO:0018931" DB="MONDO" />
              <XRef Type="MIM" ID="252600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="710" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3039" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis type 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML III</ElementValue>
                <XRef Type="MIM" ID="252600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML III ALPHA/BETA</ElementValue>
                <XRef Type="MIM" ID="252600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML IIIA</ElementValue>
                <XRef Type="MIM" ID="252600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML 3 A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudo-Hurler polydystrophy</ElementValue>
                <XRef ID="Mucolipidosis+type+3A/4909" DB="Genetic Alliance" />
                <XRef ID="65764006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis III Alpha/Beta</ElementValue>
                <XRef ID="NBK1875" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type III Mucolipidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ML3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3806" />
                <XRef ID="3806" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GNPTAB-Related Mucolipidoses</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNPTAB-related disorders comprise the phenotypes mucolipidosis II (ML II) and mucolipidosis IIIa/ß (ML IIIa/ß), and phenotypes intermediate between ML II and ML IIIa/ß. ML II is evident at birth and slowly progressive; death most often occurs in early childhood. Orthopedic abnormalities present at birth may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s). Growth often ceases in the second year of life; contractures develop in all large joints. The skin is thickened, facial features are coarse, and gingiva are hypertrophic. All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve. Progressive mucosal thickening narrows the airways, and gradual stiffening of the thoracic cage contributes to respiratory insufficiency, the most common cause of death. ML IIIa/ß becomes evident at about age three years with slow growth rate and short stature; joint stiffness and pain initially in the shoulders, hips, and fingers; gradual mild coarsening of facial features; and normal to mildly impaired cognitive development. Pain from osteoporosis becomes more severe during adolescence. Cardiorespiratory complications (restrictive lung disease, thickening and insufficiency of the mitral and aortic valves, left and/or right ventricular hypertrophy) are common causes of death, typically in early to middle adulthood. Phenotypes intermediate between ML II and ML IIIa/ß are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML IIIa/ß.</Attribute>
                <XRef ID="NBK1828" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301728</ID>
                <ID Source="BookShelf">NBK1828</ID>
              </Citation>
              <XRef ID="423461" DB="Orphanet" />
              <XRef ID="577" DB="Orphanet" />
              <XRef ID="C0033788" DB="MedGen" />
              <XRef ID="MONDO:0018931" DB="MONDO" />
              <XRef Type="MIM" ID="252600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="711" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3038" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ML II ALPHA/BETA</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucolipidosis type II</ElementValue>
                <XRef ID="MONDO:0009650" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">I cell disease</ElementValue>
                <XRef ID="Mucolipidosis+II/3706" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion cell disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leroy Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylglucosamine 1phosphotransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML disorder type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICD</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ML II</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GNPTA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GNPTAB-related disorders comprise the phenotypes mucolipidosis II (ML II) and mucolipidosis IIIa/ß (ML IIIa/ß), and phenotypes intermediate between ML II and ML IIIa/ß. ML II is evident at birth and slowly progressive; death most often occurs in early childhood. Orthopedic abnormalities present at birth may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s). Growth often ceases in the second year of life; contractures develop in all large joints. The skin is thickened, facial features are coarse, and gingiva are hypertrophic. All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve. Progressive mucosal thickening narrows the airways, and gradual stiffening of the thoracic cage contributes to respiratory insufficiency, the most common cause of death. ML IIIa/ß becomes evident at about age three years with slow growth rate and short stature; joint stiffness and pain initially in the shoulders, hips, and fingers; gradual mild coarsening of facial features; and normal to mildly impaired cognitive development. Pain from osteoporosis becomes more severe during adolescence. Cardiorespiratory complications (restrictive lung disease, thickening and insufficiency of the mitral and aortic valves, left and/or right ventricular hypertrophy) are common causes of death, typically in early to middle adulthood. Phenotypes intermediate between ML II and ML IIIa/ß are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML IIIa/ß.</Attribute>
                <XRef ID="NBK1828" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GNPTAB-Related Mucolipidoses</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6749" />
                <XRef ID="6749" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301728</ID>
                <ID Source="BookShelf">NBK1828</ID>
              </Citation>
              <XRef ID="576" DB="Orphanet" />
              <XRef ID="C2673377" DB="MedGen" />
              <XRef ID="MONDO:0009650" DB="MONDO" />
              <XRef Type="MIM" ID="252500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1954704" SubmissionDate="2019-09-20" DateLastUpdated="2019-10-20" DateCreated="2019-10-20">
        <ClinVarSubmissionID localKey="c.1959_1960delTA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000996150" DateUpdated="2019-10-20" DateCreated="2019-10-20" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 13 of 21 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function. This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is present in the heterozygous state in the gnomAD population database at a frequency of 0.0004% (1/246184) and thus is presumed to be rare. Based on the available evidence, the c.1959_1960delTA (p.Pro655HisfsTer12) variant is classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">121</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTAB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024312.4:c.1959_1960delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUCOLIPIDOSIS III ALPHA/BETA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6324741</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2996737" SubmissionDate="2021-02-21" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_024312.4:c.1959_1960delTA|OMIM:252500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001521522" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTAB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024312.4:c.1959_1960delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="252500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9109035</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1444807" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a955542" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000741015" DateUpdated="2023-01-07" DateCreated="2018-04-15" Type="SCV" Version="3" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Hispanic</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="a685624" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Multiple prenatal fractures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0005855" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Osteopenia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000938" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Growth delay</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001510" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hearing impairment</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000365" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Pulmonic stenosis (disease)</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001642" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Anteriorly placed anus</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001545" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Bowing of the legs</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002979" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Muscular hypotonia of the trunk</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0008936" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hand clenching</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001188" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Oligohydramnios</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001562" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Intrauterine growth retardation</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001511" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Atrial septal defect</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001631" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Patent ductus arteriosus after birth at term</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011648" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Periorbital fullness</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000629" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hypertelorism</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000316" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Retrognathia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000278" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Relative macrocephaly</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0004482" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Brachycephaly</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000248" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Slanting of the palpebral fissure</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0200006" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Smooth philtrum</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000319" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Thin vermilion border</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000233" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Low-set ears</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000369" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Heterochromia iridis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001100" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the skeletal system</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000924" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTAB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024312.4:c.1959_1960delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8523142" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="3739802|MedGen:C0033788;C2673377" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004568068" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19617216</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25107912</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34645491</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro655Hisfs*12) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with clinical features of mucolipdosis III alpha/beta (PMID: 34645491). ClinVar contains an entry for this variant (Variation ID: 520752). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTAB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.102158735_102158736del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0033788" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2673377" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Heterochromia iridis" MappingRef="Preferred">
        <MedGen CUI="C0423318" Name="Heterochromia iridis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8523142" TraitType="Disease" MappingType="XRef" MappingValue="C0033788" MappingRef="MedGen">
        <MedGen CUI="C0033788" Name="Pseudo-Hurler polydystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Hearing impairment" MappingRef="Preferred">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2996737" TraitType="Disease" MappingType="XRef" MappingValue="252500" MappingRef="OMIM">
        <MedGen CUI="C2673377" Name="Mucolipidosis type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Anteriorly placed anus" MappingRef="Preferred">
        <MedGen CUI="C1838705" Name="Anteriorly placed anus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Relative macrocephaly" MappingRef="Preferred">
        <MedGen CUI="C1849075" Name="Relative macrocephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Oligohydramnios" MappingRef="Preferred">
        <MedGen CUI="C0079924" Name="Oligohydramnios" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Thin vermilion border" MappingRef="Preferred">
        <MedGen CUI="C0578038" Name="Thin vermilion border" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Pulmonic stenosis (disease)" MappingRef="Preferred">
        <MedGen CUI="C1956257" Name="Pulmonic stenosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Patent ductus arteriosus after birth at term" MappingRef="Preferred">
        <MedGen CUI="C4023249" Name="Patent ductus arteriosus after birth at term" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the skeletal system" MappingRef="Preferred">
        <MedGen CUI="C4021790" Name="Abnormality of the skeletal system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Hand clenching" MappingRef="Preferred">
        <MedGen CUI="C0239815" Name="Hand clenching" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1954704" TraitType="Disease" MappingType="Name" MappingValue="MUCOLIPIDOSIS III ALPHA/BETA" MappingRef="Preferred">
        <MedGen CUI="C0033788" Name="Pseudo-Hurler polydystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Hypertelorism" MappingRef="Preferred">
        <MedGen CUI="C0020534" Name="Hypertelorism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Periorbital fullness" MappingRef="Preferred">
        <MedGen CUI="C4760994" Name="Periorbital fullness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Slanting of the palpebral fissure" MappingRef="Preferred">
        <MedGen CUI="C2748932" Name="Slanting of the palpebral fissure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Muscular hypotonia of the trunk" MappingRef="Preferred">
        <MedGen CUI="C1853743" Name="Axial hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Smooth philtrum" MappingRef="Preferred">
        <MedGen CUI="C1142533" Name="Smooth philtrum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Retrognathia" MappingRef="Preferred">
        <MedGen CUI="C0035353" Name="Retrognathia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Growth delay" MappingRef="Preferred">
        <MedGen CUI="C0456070" Name="Growth delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Osteopenia" MappingRef="Preferred">
        <MedGen CUI="C0029453" Name="Osteopenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Atrial septal defect" MappingRef="Preferred">
        <MedGen CUI="C0018817" Name="Atrial septal defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8523142" TraitType="Disease" MappingType="XRef" MappingValue="C2673377" MappingRef="MedGen">
        <MedGen CUI="C2673377" Name="Mucolipidosis type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Bowing of the legs" MappingRef="Preferred">
        <MedGen CUI="C5574706" Name="Bowing of the legs" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Brachycephaly" MappingRef="Preferred">
        <MedGen CUI="C0221356" Name="Brachycephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Intrauterine growth retardation" MappingRef="Preferred">
        <MedGen CUI="C0015934" Name="Fetal growth restriction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Low-set ears" MappingRef="Preferred">
        <MedGen CUI="C0239234" Name="Low-set ears" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444807" TraitType="Finding" MappingType="Name" MappingValue="Multiple prenatal fractures" MappingRef="Preferred">
        <MedGen CUI="C1853171" Name="Multiple prenatal fractures" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

